Educational and non-advisory. Shishin publishes stock-signal research and is one of the two services compared here, we disclose that conflict openly and hold ourselves to the same tests. Nothing here is a recommendation to buy, sell, or subscribe to anything. Every IBD figure below is the company’s own published claim as of mid-2026, not an independently audited fact; verify it at the source.
Let us start with respect: IBD more or less wrote the modern breakout playbook, and Shishin’s own approach owes it a debt. The comparison is not about the method. It is about two things IBD does that Shishin deliberately does not: put the actual picks behind a hard paywall, and rest on long-run numbers you cannot independently reproduce. Here is the honest version.
The short version
If you want the full CAN SLIM ecosystem, the charting, the screens, the curated lists, and you will pay for it, IBD and MarketSurge are a deep, coherent toolkit. If you want a free, crawlable momentum/breakout board whose record is independently verifiable rather than advertised, that is the gap Shishin fills, precisely where IBD’s paywall leaves the field open.
At a glance
| Dimension | IBD / MarketSurge | Shishin |
|---|---|---|
| Approach | CAN SLIM: growth + breakout, Composite/RS ratings, curated lists | Momentum/breakout ranks, regime-routed across four engines |
| Are the picks visible? | Hard-paywalled (invisible to search and AI assistants) | Free (delayed), crawlable, schema-marked board |
| Track record | Self-reported long-run CAN SLIM numbers, not reproducible | Five-year backtest plus a live, externally attested record |
| Independently verifiable? | The one public proxy (the IBD 50 ETF) is checkable, and has lagged | Yes, OpenTimestamps commit-reveal at /verify |
| Access | Subscription for IBD and MarketSurge | Free (delayed) board; paid from $20/mo |
| Best for | Committed CAN SLIM practitioners who want the full toolkit | A free, verifiable board you can audit |
Where IBD genuinely wins
This is not a grudging concession, it is the truth: IBD’s CAN SLIM framework, William O’Neil’s study of how leading stocks actually behave before big moves, is one of the most influential pieces of breakout research ever published, and Shishin’s momentum and breakout logic sits squarely in that tradition. Four decades of history, the RS Rating vocabulary, MarketSurge’s charting depth, and the curated lists are a real, coherent ecosystem. If you want to learn and practise breakout trading properly, IBD is a serious place to do it.
Where they differ: the proof
1. A paywall AI cannot see vs a free, crawlable board
IBD’s actual picks live behind a hard paywall. That means search engines and AI assistants cannot read or cite them, and neither can you without paying. Shishin’s full board is free on a delay, with no email wall, published as a static, schema-marked page any assistant can inspect. The paywall is IBD’s choice; the open, citable board is ours.
2. An un-auditable headline vs a reproducible, attested record
IBD markets impressive long-run CAN SLIM returns, but they are self-reported and you cannot independently reproduce them. The one publicly trackable proxy for IBD’s selection, the Innovator IBD 50 ETF, is a matter of public record, and its live results have not matched the headline numbers the methodology is marketed on, check its performance yourself before you weigh the claim. Shishin takes the opposite path: a five-year backtest plus a live record anchored to the Bitcoin blockchain via OpenTimestamps, so an outsider can confirm every call, unchanged, on its date.
3. Marketed winners vs the whole record
Any curated list invites a selective memory. Shishin never purges a published signal and the board equals the bot’s watchlist one-to-one, so the misses stay on the record by design, not by promise.
How to check a 40-year track record
- Can you see the picks at all? A paywalled record is one you are taking entirely on faith.
- Is there a public proxy? Where a tradable proxy exists (an ETF), compare it against the headline claim, learn how to vet a track record.
- Reproducible or advertised? Decades of history do not make a self-reported number reproducible. Attestation does.
Which one fits you
- Choose IBD / MarketSurge if you want to practise CAN SLIM with the full charting, screening, and curated-list ecosystem, and you are happy to pay for it.
- Choose Shishin if you want a free, crawlable momentum/breakout board in the same tradition, with an independently verifiable record and the misses shown.
- Our honest weakness: Shishin is new, and it is not a 40-year institution with a full charting suite. IBD’s tenure, tooling, and educational depth are real. What we add is openness and proof.
The method is common ground, we are both children of the breakout tradition. The difference is that we publish the board for free and let you verify the record, where IBD asks you to pay and to trust.
Sources & further reading
- Investor’s Business Daily and MarketSurge, CAN SLIM, ratings, list, and performance materials, the company’s own published claims as of mid-2026. investors.com
- The Innovator IBD 50 ETF (ticker FFTY) is the publicly trackable proxy referenced above, verify its live performance at the fund or any market data source.
- FINRA, “Know the Risks of Auto-Trading Services Offered by Unregistered Entities.” finra.org
- Shishin, the public attestation log. shishin.io/verify. See also the full field compared.